Login / Signup

Screening uptake of colonoscopy versus fecal immunochemical testing in first-degree relatives of patients with non-syndromic colorectal cancer: A multicenter, open-label, parallel-group, randomized trial (ParCoFit study).

Natalia González-LópezEnrique QuinteroAntonio Z Gimeno-GarciaLuis BujandaJesús BanalesJoaquín Cubiella FernándezMaría Salve-BouzoJesus Miguel Herrero-RivasEstela Cid-DelgadoVictoria Alvarez-SanchezAlejandro Ledo-RodríguezMaria Luisa de-Castro-PargaRomina Fernández-PoceiroLuciano Sanromán-ÁlvarezJosé Santiago GarcíaAlberto Herreros-de-TejadaTeresa Ocaña-BombardoFrancesc BalaguerMaría Rodríguez-SolerRodrigo JoverMarta PonceCristina Alvarez-UrturiXavier BessaMaria-Pilar RoncalesFederico SopeñaAngel LanasDavid Nicolás-PérezZaida Adrián-de-GanzoMarta Carrillo-PalauEnrique Francisco González Dávilanull null
Published in: PLoS medicine (2023)
This trial was registered with ClinicalTrials.gov (NCT02567045).
Keyphrases
  • open label
  • phase iii
  • clinical trial
  • phase ii
  • study protocol
  • intellectual disability
  • cross sectional
  • squamous cell carcinoma
  • autism spectrum disorder
  • phase ii study